New Market, MD, United States of America

Megan Kimicata

This inventor holds 1 USPTO granted patent. Top assignee: University System of Maryland. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Megan Kimicata. Retrieved from https://idiyas.com/inventor/megan-kimicata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Megan Kimicata and 3D-Printed UV Crosslinking Masks.

Introduction

Megan Kimicata is an inventor associated with New Market, Maryland. Her work addresses a challenge in small-diameter vascular grafts: uneven physiological conditions along a graft can contribute to thrombus formation and eventual graft failure.

Latest Patents

Kimicata is associated with 1 patent, titled “3D Printed UV Crosslinking Masks.” The described approach places a heparin-loaded gelatin methacrylate interlayer between a biohybrid graft made from decellularized bovine pericardium and poly(propylene fumarate). Three-dimensional printed shadow masks control UV exposure, allowing the interlayer’s crosslinking and properties to be adjusted by varying the light reaching the graft.

The system is designed to provide sustained, spatially controlled heparin delivery. The supplied description reports that slower, sustained exposure allows endothelial cells to behave similarly to untreated cells, while slower release profiles produce significantly more tissue factor pathway inhibitor release than faster profiles.

Career Highlights

Kimicata’s listed work connects biomaterials, vascular graft design, and controlled drug delivery. The supplied information identifies the University System of Maryland as her company affiliation.

Collaborations

John Patrick Fisher is listed as Kimicata’s coworker. The supplied information does not specify further details about their collaboration.

Conclusion

Megan Kimicata’s described invention uses 3D-printed masks to regulate UV crosslinking and support controlled heparin delivery in vascular grafts.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…